PPIs and anti-TNF in patients with IBD: a forbidden combination?

Autor: Wellens J; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium Judith.wellens@kuleuven.be.; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium., Sabino J; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium.; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium.; Department of Chronic Diseases Metabolism and Ageing, KU Leuven University Hospitals Leuven Campus Gasthuisberg, Leuven, Flanders, Belgium., Vermeire S; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium.; Department of Chronic Diseases Metabolism and Ageing, KU Leuven University Hospitals Leuven Campus Gasthuisberg, Leuven, Flanders, Belgium.
Jazyk: angličtina
Zdroj: Gut [Gut] 2021 Dec; Vol. 70 (12), pp. 2397-2398. Date of Electronic Publication: 2021 Jan 29.
DOI: 10.1136/gutjnl-2021-324040
Abstrakt: Competing Interests: Competing interests: None declared.
Databáze: MEDLINE